Alterations of Bioactive Lipid Profiles in the Retina Following Traumatic Optic Neuropathy in Mice
Open Access
- 14 October 2025
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1450
Abstract
Traumatic optic neuropathy (TON) causes vision loss through compression and contusion, yet there is no consensus on the most effective treatment. Polyunsaturated fatty acid (PUFA)-derived bioactive lipids metabolized by lipoxygenase (LOX), cytochrome P450 (CYP), and cyclooxygenase (COX) enzymes are known mediators of inflammation and neurodegeneration. However, their role in TON-related retinal pathology remains unclear. Controlled orbital impact (COI) was used to induce unilateral TON in mice with controlled velocity (2–3 m/s), with the fellow eye serving as an internal control. Retina tissues were collected three days post-injury and analyzed by LC/MS to quantify bioactive lipid metabolites from ω−6 and ω−3 PUFAs. Statistical analysis was performed using paired, nonparametric Wilcoxon signed-rank tests with Benjamini–Hochberg false discovery rate (FDR) correction. Results showed that among 38 reliably detected metabolites, no individual lipid showed a statistically significant difference between TON and control eyes after FDR correction (q < 0.05). However, both individual and pathway-level analysis revealed consistent trends toward increased expression of LOX- and CYP-derived metabolites across FDA PUFA substrates, including arachidonic acid (AA), linoleic acid (LA), and docosahexaenoic acid (DHA). These findings support further investigation into lipid-mediated inflammation in TON and its potential as a therapeutic target, particularly through expanding both the sample size and the post-TON time periods.Keywords
Funding Information
- National Eye Institute (R01-EY023315, R21-EY036537, R01-EY030054)
- NIH CORE (P30EY004068)
- National Institutes of Health (S10OD032292, 1R01EY034964-01, P30EY004068)
This publication has 51 references indexed in Scilit:
- Traumatic optic neuropathy: a review of current studiesNeurosurgical Review, 2022
- Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trialClinical Nutrition, 2021
- Traumatic Optic Neuropathy and Second Optic Nerve InjuriesJAMA Ophthalmology, 2014
- A mouse model of ocular blast injury that induces closed globe anterior and posterior pole damageExperimental Eye Research, 2012
- Traumatic Optic Neuropathy: An Evolving UnderstandingAmerican Journal of Ophthalmology, 2011
- Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burstJournal of Biosciences, 2007
- High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trialGraefe's Archive for Clinical and Experimental Ophthalmology, 2007
- 15d-PGJ2: The anti-inflammatory prostaglandin?Clinical Immunology, 2005
- Effects of the Arachidonate Lipoxygenase Inhibitor BW755C on Traumatic and Peritumoural Brain Oedema1990
- Cardiovascular effects of prostaglandin D3 and D2 in anesthetized dogsProstaglandins, 1981